Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Ocean Power Technologies priced a public offering of 6,000,000 shares of common stock and accompanying warrants at a combined price of $0.50 per unit. The company expects to receive gross proceeds of $3.0 million to be used for working capital and general corporate purposes. D. Boral Capital LLC is acting as the exclusive placement agent for the transaction.
Nine Energy Service Signs $7M M&A Deal with American Cementing, LLC
Nine Energy Service has entered into a definitive agreement to acquire American Cementing, LLC for $7.0 million in cash and 3.93 million shares of common stock. The acquisition is expected to increase Nine's revenue by more than 35% and expand its cementing footprint into the Rockies, Bakken, and Northeast regions. The deal is expected to close in Q1 2027, subject to stockholder approval and customary closing conditions.
Value
$7M
Counterparty
American Cementing, LLC
“This is a transformative step for Nine. American Cementing is a premier operator with a strong reputation, an outstanding team and a footprint that fits well with ours. The acquisition will give us the scale and geographic reach to serve customers across more of the key U.S. basins, while strengthening our balance sheet at the same time.”
Ann Fox, President and Chief Executive Officer
“American Cementing and Nine share a deep commitment to customers, employees, safety and operational execution. That shared culture gives me great confidence in the combined company, and I look forward to supporting Nine as we bring these two high-quality organizations together.”
Steve Mitchell, CEO and Managing Director of Argonaut
Artificial Intelligence Technology Solutions' subsidiary, Robotic Assistance Devices (RAD), has launched a new Glass Break Detection AI analytic for its ROAMEO autonomous security patrol vehicle. The feature, developed over 17 months, allows the mobile robot to detect the sound of breaking glass and initiate automated investigation and evidence capture. This marks the fifth release of 15 engineering initiatives committed to by the company in July 2026.
Powerus M&A Deal with Autonomous Power Corporation
Powerus Corporation filed historical and pro forma financial statements related to its completed merger with Autonomous Power Corporation (Legacy Powerus). The merger, which closed on October 1, 2026, resulted in Legacy Powerus becoming a direct subsidiary of the company.
Aclaris Therapeutics announced that its Phase 2 ADMIRATION trial of bosakitug (ATI-045) for moderate-to-severe atopic dermatitis failed to meet its primary and secondary endpoints. Despite robust target engagement and biomarker downregulation, the company will shift focus toward its oral ITK inhibitors and bispecific antibody ATI-052. The company also announced the initiation of a Phase 2b trial for modzatinib in lichen planus and plans to file an IND for ATI-9494 in Q4 2026.
Vir Biotechnology entered into an underwriting agreement to sell 15,000,000 shares of common stock at a public offering price of $10.00 per share. The company expects to receive approximately $140.4 million in net proceeds, or $161.5 million if the underwriters exercise their 30-day option to purchase an additional 2,250,000 shares.
Rezolute, Inc. entered into an underwriting agreement for a public offering of 22,040,976 shares of common stock and 3,800,000 pre-funded warrants, expected to raise gross proceeds of approximately $100 million. The financing was led by Frazier Life Sciences and is intended to fund commercialization preparation for ersodetug and general corporate purposes.
KALA BIO received a determination from the Nasdaq Hearings Panel granting its request to continue its listing on The Nasdaq Capital Market subject to specific conditions. The company must evidence a closing bid price of at least $1.00 per share for ten consecutive business days by November 30, 2026, and maintain that price through February 23, 2027. Failure to meet these conditions or any other listing rules during this period may result in delisting.
DataMEDS AI, Inc. entered into an at-the-market (ATM) sales agreement with Dawson James Securities, Inc. to establish an offering program for its common stock. The company may sell shares from time to time at prevailing market prices, though it is not obligated to make any sales. The Sales Agent will receive a fixed commission of 3.0% of the gross proceeds from any shares sold.
CorMedix Inc. announced a definitive agreement to acquire substantially all of the assets of Heron Therapeutics, Inc., including both commercial and pipeline assets. The acquisition is intended to provide scale and diversification to CorMedix's institutional care growth strategy and remains subject to Heron stockholder approval and regulatory clearance.
Greenland Energy Company has reached a definitive agreement to acquire the entire issued share capital of 80 Mile plc (AIM: 80M) in an all-share transaction. Under the terms, 80 Mile shareholders will receive 0.0079485 shares of Greenland common stock for each share held, implying a deal value of approximately £74 million. The acquisition will be implemented via a court-sanctioned scheme of arrangement and includes the appointment of one 80 Mile director to the Greenland board.
Nakamoto Inc. entered into an amended and restated sales agreement to maintain an at-the-market (ATM) offering program for up to $4.99 billion of common stock. The amendment updates the group of sales agents, adding Muriel Siebert & Co., LLC and Maxim Group LLC while terminating the participation of several previous agents.
Mistras Group provided a status update on its pending acquisition by Athena Purchaser, LLC (an affiliate of H.I.G. Capital), disclosing that two lawsuits and multiple demand letters have been filed by stockholders alleging deficient disclosures in the merger proxy statement. The company maintains that the claims are without merit but is filing supplemental disclosures ahead of the special stockholder meeting scheduled for November 24, 2026.
CareTrust REIT entered into forward sale agreements for 19,550,000 shares of common stock at an initial forward price of $36.00 per share. The transaction includes an initial 17,000,000 shares and the full exercise of an underwriters' option for an additional 2,550,000 shares. The company intends to physically settle the agreements for cash proceeds by November 12, 2027, to fund future acquisitions and for general corporate purposes.
Value
$704M
Counterparty
BofA Securities, Inc. and Morgan Stanley & Co. LLC
Flux Power Holdings received a deficiency notice from Nasdaq on November 9, 2026, for failing to maintain the minimum $2.5 million stockholders' equity requirement. The company has until December 24, 2026, to submit a plan to regain compliance and is also working to meet an extended December 4 deadline for a $4.0 million equity raise required by its lender, Gibraltar Business Capital.
Datavault AI received a delisting notice from Nasdaq due to non-compliance with the $1.00 minimum bid price requirement and a closing bid price below $0.10 for ten consecutive business days. Trading on Nasdaq will be suspended effective November 17, 2026, at which point the company expects its common stock to begin trading on the OTC Markets. The company intends to request a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension to maintain its listing.
AiRWA Inc. entered into securities purchase agreements with certain investors to sell 1,800,000 shares of common stock at $0.8332 per share. The transaction is expected to generate gross proceeds of approximately $1.5 million for working capital and general corporate purposes. The offering was conducted as a private placement in reliance on Section 4(a)(2) and Regulation D.
Accuray completed a $55 million financing transaction with its primary lender TCW, involving the issuance of 55,000 shares of Series A Convertible Preferred Stock. The deal includes $15 million in new cash capital and the conversion of $40 million of existing debt into equity, significantly deleveraging the balance sheet.
Contango Silver & Gold Inc. entered into a Controlled Equity Offering Sales Agreement to establish an at-the-market (ATM) offering program. The company may sell shares of common stock from time to time with an aggregate offering price of up to $75 million. Cantor Fitzgerald & Co. is acting as the lead agent for the program.
Q/C Technologies received a deficiency notice from Nasdaq on November 6, 2026, because its common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The company has 180 calendar days, or until May 5, 2027, to regain compliance with the minimum bid price requirement. If compliance is not regained, the company may be eligible for an additional 180-day period or face delisting.
INNOVATE Corp. filed a prospectus supplement to establish a new $50 million at-the-market (ATM) equity offering program through Jefferies LLC. This program replaces a previous registration statement that expired in October 2026 and increases the potential offering amount from $31 million to $50 million. The filing also includes pro forma financial data reflecting the company's recent divestitures of its Broadcasting and DBM Global business units.
Hall Chadwick Acquisition Signs $400M M&A Deal with REEcycle Holdings, Inc.
Hall Chadwick Acquisition Corp. (HCAC) announced that the SEC has declared effective its Form S-4 registration statement for its proposed $400 million business combination with REEcycle Holdings, Inc. A shareholder meeting to vote on the merger is scheduled for December 10, 2026, with the deal expected to close by year-end. Upon completion, REEcycle will become a Nasdaq-listed company focused on domestic rare-earth element recycling technology.
Andersen Group Signs $90.3M M&A Deal with Nodaservizi S.r.l.
Andersen Group Inc. announced three separate acquisitions of professional services firms in Italy, Poland, and the U.S. for a combined aggregate consideration of approximately $90.3 million. The deals involve Nodaservizi S.r.l. ($58.2M), Andersen Outsourcing and related Polish entities ($7.3M), and 1Rivet LLC ($24.8M), with all transactions utilizing a mix of cash and Class A Common Stock. All three acquisitions are expected to close in the first quarter of 2027 subject to customary conditions.
Value
$90.3M
Counterparty
Nodaservizi S.r.l.; Andersen Outsourcing sp. z o.o.; 1Rivet LLC
Agility Robotics M&A Deal with Old Robot Holdings, Inc.
Agility Robotics, Inc. filed an amendment to its 8-K to provide required financial statements and pro forma information following the consummation of its business combination with Old Robot Holdings, Inc. (Legacy Agility). The filing includes unaudited condensed financial statements for Legacy Agility as of September 30, 2026, and related management discussion.
Singularity Future Technology received a delisting notice from Nasdaq on November 10, 2026, because its stock price remained below the $1.00 minimum bid requirement for 30 consecutive business days. Because the company completed a reverse stock split within the past year, it is ineligible for a standard 180-day grace period and faces immediate suspension unless it successfully appeals to a Nasdaq Hearings Panel. Separately, shareholders approved the future issuance of 250 million shares and approximately 6.9 million warrants at a special meeting.
Callan JMB Inc. entered into a securities purchase agreement for a private placement of 1,363,639 shares of common stock at $1.10 per share, raising approximately $1.5 million in gross proceeds. The offering was led by Chairman and CEO Wayne Williams and other company insiders, with the purchase price representing a premium to the market price. Proceeds will be used for strategic growth initiatives and general corporate purposes.
Value
$1.5M
Counterparty
Wayne Williams
“Our leadership team is putting its own capital to work because we believe in the path ahead. This is a direct expression of our confidence in the Company’s strategy, and our commitment to building value alongside shareholders.”
Wayne Williams, Chief Executive Officer of Callan JMB
“We believe the strongest signal we can send is to invest our own capital at a price that is at a multiple above the current market, but still at what we perceive to be a discount to the true value of our shares. Investing alongside our shareholders demonstrates our confidence in the company.”
Christopher Shields, Interim Chief Financial Officer
Miluna Acquisition M&A Deal with CADV Ventures S.A.
Miluna Acquisition Corp entered into an amendment to its existing business combination agreement with CADV Ventures S.A. and Kukugan Invest. The amendment extends the deal's outside closing date from January 23, 2027, to April 23, 2027, and modifies lock-up requirements for certain advisory firms involved in the transaction.
Bowhead Specialty Holdings M&A Deal with American Family Mutual Insurance Company, S.I.
Bowhead Specialty Holdings stockholders approved the company's acquisition by American Family Mutual Insurance Company, S.I. at a special meeting held on November 13, 2026. Additionally, CFO and Treasurer Brad Mulcahey announced his intention to depart the company in April 2027, though his departure is not due to any disagreements with the company.
Erp Operating Ltd Partnership M&A Deal with AvalonBay Communities, Inc.
Vivmark Residential (formerly Equity Residential) and ERP Operating Limited Partnership filed updated pro forma financial information following the completion of their merger with AvalonBay Communities, Inc. The transaction was accounted for as a reverse acquisition where AvalonBay was the accounting acquirer, with its stockholders owning 51% of the combined company. The filing provides updated condensed consolidated statements of operations for the year ended 2025 and the first nine months of 2026 to reflect the combined entity.
Valaris Limited provided a status update regarding its pending merger with Transocean Ltd., specifically addressing demand letters from shareholders alleging disclosure deficiencies in the proxy statement. To avoid potential delays to the business combination, Valaris is voluntarily providing supplemental disclosures to the definitive joint proxy statement ahead of the shareholder vote scheduled for November 24, 2026.